NICE rules out RA drug abatacept

The rheumatoid arthritis (RA) drug abatacept is too expensive to be prescribed on the NHS, according to NICE.

In a draft single technology appraisal of the drug, released last week, NICE said abatacept was as effective as the other cytokine inhibitor rituximab for RA, but cost twice as much.

Rituximab was recently approved for use with methotrexate in RA patients who failed to respond to other disease-modifying anti-rheumatic drugs (DMARDs).

A NICE spokesman said: 'While recognising the severity of RA, it was concluded that based on this evidence, abatacept could not be considered good use of NHS resources.'

Chief executive of the National Rheumatoid Arthritis Society Ailsa Bosworth said: 'To deny patients abatacept is to deny people with an aggressive and severe form of RA a chance of controlling the disease.'

Last week NICE issued final guidance on the use of tumour necrosis factor alpha blockers for RA. Adalimumab, etanercept and infliximab are recommended in patients with confirmed active RA who have already been trialled with at least two other DMARDs, including methotrexate.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...